The PERSEVERE Trial: Advancing Evidence in High-Risk PE
Global Principal Investigators discuss the design and impact of a randomized trial evaluating the FlowTriever System versus standard of care for high-risk pulmonary embolism.
With Stavros V. Konstantinides, MD, PhD, and Nicolas Meneveau, MD, PhD
